{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T19:33:05Z","timestamp":1692819185868},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00108-020-00831-y","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T12:03:44Z","timestamp":1594209824000},"page":"860-868","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tumorerkrankungen an der Haut erkennen \u2013 paraneoplastische Hauterkrankungen"],"prefix":"10.1007","volume":"61","author":[{"given":"B.","family":"Gualtieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hertl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"issue":"8","key":"831_CR1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00108-019-0636-1","volume":"60","author":"T Khoschbin","year":"2019","unstructured":"Khoschbin\u00a0T, L\u00f6ser\u00a0C, Dippel\u00a0E (2019) Paraneoplastic skin diseases. Internist 60(8):775\u2013782","journal-title":"Internist"},{"issue":"1","key":"831_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/S0365-05962013000100001","volume":"88","author":"JA Silva","year":"2013","unstructured":"Silva\u00a0JA, Mesquita Kde\u00a0C, Igreja\u00a0AC et\u00a0al (2013) Paraneoplastic cutaneous manifestations: concepts and updates. An Bras Dermatol 88(1):9\u201322","journal-title":"An Bras Dermatol"},{"issue":"3","key":"831_CR3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5826\/dpc.0803a09","volume":"8","author":"S Caccavale","year":"2018","unstructured":"Caccavale\u00a0S, Brancaccio\u00a0G, Agozzino\u00a0M et\u00a0al (2018) Obligate and facultative paraneoplastic dermatoses: an overview. Dermatol Pract Concept 8(3):191\u2013197","journal-title":"Dermatol Pract Concept"},{"key":"831_CR4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4103\/0378-6323.51249","volume":"75","author":"MS Ljubenovic","year":"2009","unstructured":"Ljubenovic\u00a0MS, Ljubenovic\u00a0DB, Binic\u00a0II et\u00a0al (2009) Acrokeratosis paraneoplastica (Bazex syndrome). Indian J Dermatol Venereol Leprol 75:329","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"831_CR5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1157\/13097001","volume":"43","author":"MT R\u00edo Ram\u00edrez","year":"2007","unstructured":"R\u00edo Ram\u00edrez\u00a0MT, Casado L\u00f3pez\u00a0ME, Peir\u00f3n Puyal\u00a0MJ et\u00a0al (2007) Pulmonary adenocarcinoma and Bazex syndrome (paraneoplastic acrokeratosis). Arch Bronconeumol 43:46\u201348","journal-title":"Arch Bronconeumol"},{"key":"831_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3322\/caac.20005","volume":"59","author":"BH Thiers","year":"2009","unstructured":"Thiers\u00a0BH, Sahn\u00a0RE, Callen\u00a0JP (2009) Cutaneous manifestations of internal malignancy. CA Cancer J Clin 59:73\u201398","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"831_CR7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ad.2013.09.008","volume":"105","author":"A Plascencia G\u00f3mez","year":"2014","unstructured":"Plascencia G\u00f3mez\u00a0A, Vega Memije\u00a0ME, Torres Tamayo\u00a0M et\u00a0al (2014) Skin disorders in overweight and obese patients and their relationship with insulin. Actas Dermosifiliogr 105(2):178\u2013185","journal-title":"Actas Dermosifiliogr"},{"issue":"12","key":"831_CR8","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamadermatol.2015.2139","volume":"151","author":"HC Lee","year":"2015","unstructured":"Lee\u00a0HC, Ker\u00a0KJ, Chong\u00a0WS (2015) Oral malignant acanthosis Nigricans and tripe palms associated with renal urothelial carcinoma. JAMA Dermatol 151(12):1381\u20131383","journal-title":"JAMA Dermatol"},{"key":"831_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.det.2007.08.002","volume":"26","author":"CA Pipkin","year":"2008","unstructured":"Pipkin\u00a0CA, Lio\u00a0PA (2008) Cutaneous manifestations of internal malignancies: an overview. Dermatol Clin 26:1\u201315","journal-title":"Dermatol Clin"},{"key":"831_CR10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1067\/j.cpsurg.2010.01.003","volume":"47","author":"BD Ehst","year":"2010","unstructured":"Ehst\u00a0BD, Minzer-Conzetti\u00a0K, Swerdlin\u00a0A, Devere\u00a0TS (2010) Cutaneous manifestations of internal malignancy. Curr Probl Surg 47:384\u2013445","journal-title":"Curr Probl Surg"},{"issue":"5","key":"831_CR11","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1111\/ijd.12096","volume":"54","author":"O Onajin","year":"2015","unstructured":"Onajin\u00a0O, Comfere\u00a0NI (2015) Co-occurrence of malignant acanthosis nigricans and the Leser-Tr\u00e9lat sign in a\u00a0patient with hepatocellular carcinoma. Int J Dermatol 54(5):e146\u2013e148","journal-title":"Int J Dermatol"},{"key":"831_CR12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0001-7310(05)73062-3","volume":"96","author":"F Mendoza-Guil","year":"2005","unstructured":"Mendoza-Guil\u00a0F, Hern\u00e1ndez-Jurado\u00a0I, Burkhardt\u00a0P et al (2005) Necrolytic migratory erythema associated with glucagonoma. Actas Dermosifiliogr 96:175\u2013178","journal-title":"Actas Dermosifiliogr"},{"key":"831_CR13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1590\/S1807-59322008000200016","volume":"63","author":"RC Teixeira","year":"2008","unstructured":"Teixeira\u00a0RC, Nico\u00a0MM, Ghideti\u00a0AC (2008) Necrolytic migratory erythema associated with glucagonoma: a\u00a0report of 2 cases. Clinics 63:267\u2013270","journal-title":"Clinics"},{"key":"831_CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1590\/S0041-87812001000600005","volume":"56","author":"CC Dal Coleto","year":"2001","unstructured":"Dal Coleto\u00a0CC, de Mello\u00a0AP, Piquero-Casals\u00a0J et al (2001) Necrolytic migratory erythema associated with glucagonoma syndrome: a\u00a0case report. Rev Hosp Clin Fac Med Sao Paulo 56:183\u2013188","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"issue":"6","key":"831_CR15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.blre.2017.07.003","volume":"31","author":"AW Li","year":"2017","unstructured":"Li\u00a0AW, Yin\u00a0ES, Stahl\u00a0M et\u00a0al (2017) The skin as a\u00a0window to the blood: cutaneous manifestations of myeloid malignancies. Blood Rev 31(6):370\u2013388","journal-title":"Blood Rev"},{"issue":"3","key":"831_CR16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/bjd.14877","volume":"176","author":"L Maier","year":"2017","unstructured":"Maier\u00a0L, Udvardi\u00a0A, Hertl\u00a0M et al (2017) Paraneoplastic pemphigus with anti-BP180 autoantibodies and Castleman disease. Br J Dermatol 176(3):824\u2013826","journal-title":"Br J Dermatol"},{"issue":"5","key":"831_CR17","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/bjd.15389","volume":"176","author":"K Okahashi","year":"2017","unstructured":"Okahashi\u00a0K, Oiso\u00a0N, Ishii\u00a0N et al (2017) Paraneoplastic pemphigus associated with Castleman disease: progression from mucous to mucocutaneous lesions with epitope-spreading phenomena. Br J Dermatol 176(5):1406\u20131409","journal-title":"Br J Dermatol"},{"key":"831_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01413","author":"F Solimani","year":"2019","unstructured":"Solimani\u00a0F, Maglie\u00a0R, Pollmann\u00a0R, Schmidt\u00a0T, Schmidt\u00a0A, Ishii\u00a0N, Tackenberg\u00a0B, Pickert\u00a0J, Kirschbaum\u00a0A, Eming\u00a0R, Hashimoto\u00a0T, Hertl\u00a0M (2019) Thymoma-associated paraneoplastic autoimmune multiorgan syndrome\u2014from pemphigus to lichenoid dermatitis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.01413","journal-title":"Front Immunol"},{"issue":"10","key":"831_CR19","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.autrev.2018.04.008","volume":"17","author":"KT Amber","year":"2018","unstructured":"Amber\u00a0KT, Valdebran\u00a0M, Grando\u00a0SA (2018) Paraneoplastic autoimmune multiorgan syndrome (PAMS): beyond the single phenotype of paraneoplastic pemphigus. Autoimmun Rev 17(10):1002\u20131010","journal-title":"Autoimmun Rev"},{"key":"831_CR20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF02893355","volume":"3","author":"N Bakos","year":"1997","unstructured":"Bakos\u00a0N, Krasznai\u00a0G, B\u00e9g\u00e1ny \u00c1 (1997) Erythema gyratum repens an immunological paraneoplastic dermatosis. Pathol Oncol Res 3:59\u201361","journal-title":"Pathol Oncol Res"},{"key":"831_CR21","first-page":"197","volume":"18","author":"V Serr\u00e3o","year":"2008","unstructured":"Serr\u00e3o\u00a0V, Martins\u00a0A, Ponte\u00a0P et\u00a0al (2008) Erythema gyratum repens as the initial manifestation of lung cancer. Eur J Dermatol 18:197\u2013198","journal-title":"Eur J Dermatol"},{"key":"831_CR22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill\u00a0CL, Zhang\u00a0Y, Sigurgeirsson\u00a0B et al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a\u00a0population-based study. Lancet 357:96\u2013100","journal-title":"Lancet"},{"issue":"7","key":"831_CR23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/OGX.0b013e3181efb12a","volume":"65","author":"D Levine","year":"2010","unstructured":"Levine\u00a0D, Miller\u00a0S, Al-Dawsari\u00a0N, Barak\u00a0O, Gottlieb\u00a0AB (2010) Paraneoplastic dermatoses associated with gynecologic and breast malignancies. Obstet Gynecol Surv 65(7):455\u2013461","journal-title":"Obstet Gynecol Surv"},{"issue":"5","key":"831_CR24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11926-018-0733-5","volume":"20","author":"PW Wolstencroft","year":"2018","unstructured":"Wolstencroft\u00a0PW, Fiorentino\u00a0DF (2018) Dermatomyositis clinical and pathological phenotypes associated with myositis-specific autoantibodies. Curr Rheumatol Rep 20(5):28","journal-title":"Curr Rheumatol Rep"},{"key":"831_CR25","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-79313-7","volume-title":"Dermatomyositis: advances in recognition, understanding and management","author":"L Dourmishev","year":"2009","unstructured":"Dourmishev\u00a0L, Dourmishev\u00a0A (2009) Dermatomyositis: advances in recognition, understanding and management. Springer, Berlin"},{"issue":"3","key":"831_CR26","first-page":"191","volume":"17","author":"D Bruch-Gerharz","year":"2007","unstructured":"Bruch-Gerharz\u00a0D, Hertl\u00a0M, Ruzicka\u00a0T (2007) Mucous membrane pemphigoid: clinical aspects, immunopathological features and therapy. Eur J Dermatol 17(3):191\u2013200","journal-title":"Eur J Dermatol"},{"issue":"1","key":"831_CR27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/jdv.13397","volume":"30","author":"KT Amber","year":"2016","unstructured":"Amber\u00a0KT, Bloom\u00a0R, Hertl\u00a0M (2016) A systematic review with pooled analysis of clinical presentation and immunodiagnostic testing in mucous membrane pemphigoid: association of anti-laminin-332 IgG with oropharyngeal involvement and the usefulness of ELISA. J\u00a0Eur Acad Dermatol Venereol 30(1):72\u201377","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"831_CR28","first-page":"1339","volume":"16","author":"SC Hofmann","year":"2018","unstructured":"Hofmann\u00a0SC, Juratli\u00a0HA, Eming\u00a0R (2018) Bullous autoimmune dermatoses. J\u00a0Dtsch Dermatol Ges 16(11):1339\u20131358","journal-title":"J Dtsch Dermatol Ges"},{"issue":"9271","key":"831_CR29","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/S0140-6736(00)04971-0","volume":"357","author":"CA Egan","year":"2001","unstructured":"Egan\u00a0CA, Lazarova\u00a0Z, Darling\u00a0TN, Yee\u00a0C et al (2001) Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet 357(9271):1850\u20131851","journal-title":"Lancet"},{"issue":"1","key":"831_CR30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1590\/abd1806-4841.20187031","volume":"93","author":"AS Vacas","year":"2018","unstructured":"Vacas\u00a0AS, Bollea-Garlatti\u00a0ML, Torre\u00a0AC, Galimberti\u00a0RL (2018) Bullous pyoderma gangrenosum as a\u00a0predictor of hematological malignancies. An Bras Dermatol 93(1):133\u2013134","journal-title":"An Bras Dermatol"},{"issue":"4","key":"831_CR31","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1590\/abd1806-4841.20187353","volume":"93","author":"DG Cunha","year":"2018","unstructured":"Cunha\u00a0DG, Campos-do-Carmo\u00a0G, Marujo\u00a0JM, Verardino\u00a0GC (2018) Paraneoplastic sweet\u2019s syndrome. An Bras Dermatol 93(4):576\u2013578","journal-title":"An Bras Dermatol"},{"issue":"5","key":"831_CR32","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3892\/ijo.2013.1874","volume":"42","author":"S Raza","year":"2013","unstructured":"Raza\u00a0S, Kirkland\u00a0RS, Patel\u00a0AA, Shortridge\u00a0JR, Freter\u00a0C (2013) Insight into Sweet\u2019s syndrome and associated-malignancy: a\u00a0review of the current literature. Int J Oncol 42(5):1516\u20131522","journal-title":"Int J Oncol"},{"issue":"2","key":"831_CR33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1590\/abd1806-4841.20153189","volume":"90","author":"LL Lopes Filho","year":"2015","unstructured":"Lopes Filho\u00a0LL, Lopes\u00a0IM, Lopes\u00a0LR et\u00a0al (2015) Mammary and extramammary Paget\u2019s disease. An Bras Dermatol 90(2):225\u2013231","journal-title":"An Bras Dermatol"},{"issue":"6","key":"831_CR34","first-page":"448","volume":"9","author":"G Wagner","year":"2011","unstructured":"Wagner\u00a0G, Sachse\u00a0MM (2011) Extramammary Paget disease\u2014clinical appearance, pathogenesis, management. J\u00a0Dtsch Dermatol Ges 9(6):448\u2013454","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4","key":"831_CR35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0001-7310(08)74689-1","volume":"99","author":"L Hueso","year":"2008","unstructured":"Hueso\u00a0L, Requena\u00a0C, Alfaro-Rubio\u00a0A, Serra-Guill\u00e9n\u00a0C (2008) Paraneoplastic ichthyosis. Actas Dermosifiliogr 99(4):317\u2013318","journal-title":"Actas Dermosifiliogr"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-020-00831-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-020-00831-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-020-00831-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T23:12:22Z","timestamp":1625699542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-020-00831-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1007\/s00108-020-00831-y","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,8]]},"assertion":[{"value":"8 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"B.\u00a0Gualtieri und M.\u00a0Hertl geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}